Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Long-term complete response in a patient with postoperative recurrent ALK-rearranged lung adenocarcinoma treated with crizotinib: A case report.

Kosaka T, Yajima T, Yamaki E, Nakazawa S, Tomizawa K, Onozato R, Yamazaki A, Hirato J, Yatabe Y, Shimizu K, Mogi A, Shirabe K.

Mol Clin Oncol. 2019 Sep;11(3):309-312. doi: 10.3892/mco.2019.1892. Epub 2019 Jul 3.

2.

Fas/FasL signaling is critical for the survival of exhausted antigen-specific CD8+ T cells during tumor immune response.

Yajima T, Hoshino K, Muranushi R, Mogi A, Onozato R, Yamaki E, Kosaka T, Tanaka S, Shirabe K, Yoshikai Y, Kuwano H.

Mol Immunol. 2019 Mar;107:97-105. doi: 10.1016/j.molimm.2019.01.014. Epub 2019 Jan 30.

PMID:
30711908
3.

Prognostic significance of PD-L1 expression and tumor infiltrating lymphocytes in large cell neuroendocrine carcinoma of lung.

Ohtaki Y, Kaira K, Atsumi J, Nagashima T, Kawashima O, Ibe T, Kamiyoshihara M, Onozato R, Fujita A, Yazawa T, Sugano M, Iijima M, Nakazawa S, Obayashi K, Kosaka T, Yajima T, Kuwano H, Shirabe K, Mogi A, Shimizu K.

Am J Transl Res. 2018 Oct 15;10(10):3243-3253. eCollection 2018.

4.

High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.

Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Bai T, Kawabata-Iwakawa R, Asao T, Kaira K, Nishiyama M, Kuwano H.

Ann Surg Oncol. 2017 Dec;24(13):4017-4024. doi: 10.1245/s10434-017-6083-0. Epub 2017 Sep 20.

PMID:
28933054
5.

SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer.

Azuma Y, Yokobori T, Mogi A, Altan B, Yajima T, Kosaka T, Onozato R, Yamaki E, Asao T, Nishiyama M, Kuwano H.

J Surg Oncol. 2015 Aug;112(2):231-7. doi: 10.1002/jso.23975. Epub 2015 Jul 15.

PMID:
26180037
6.

Video-Assisted Thoracoscopic Surgery after Preoperative CT-Guided Lipiodol Marking of Small or Impalpable Pulmonary Nodules.

Mogi A, Yajima T, Tomizawa K, Onozato R, Tanaka S, Kuwano H.

Ann Thorac Cardiovasc Surg. 2015;21(5):435-9. doi: 10.5761/atcs.oa.15-00018. Epub 2015 May 25.

7.

Src kinase-associated phosphoprotein2 expression is associated with poor prognosis in non-small cell lung cancer.

Kuranami S, Yokobori T, Mogi A, Altan B, Yajima T, Onozato R, Azuma Y, Iijima M, Kosaka T, Kuwano H.

Anticancer Res. 2015 Apr;35(4):2411-5.

PMID:
25862907
8.

Single-incision laparoscopic surgery for a small-intestinal gastrointestinal stromal tumor: report of a case.

Sakai M, Wada W, Kimura S, Okada A, Hirakata T, Onozato R, Saito K, Morohara K, Osawa H, Katayama K, Yasuda N, Tanaka S, Kuwano H.

Int Surg. 2014 Jul-Aug;99(4):463-6. doi: 10.9738/INTSURG-D-13-00117.1.

9.

Relapsed cervicomediastinal lymph node carcinoma with an unknown primary site treated with TS-1 alone: a case report.

Yajima T, Onozato R, Shitara Y, Mogi A, Tanaka S, Kuwano H.

BMC Res Notes. 2013 Dec 27;6:558. doi: 10.1186/1756-0500-6-558.

10.

FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCs.

Yokobori T, Yokoyama Y, Mogi A, Endoh H, Altan B, Kosaka T, Yamaki E, Yajima T, Tomizawa K, Azuma Y, Onozato R, Miyazaki T, Tanaka S, Kuwano H.

Mol Cancer Res. 2014 Jan;12(1):32-7. doi: 10.1158/1541-7786.MCR-13-0341. Epub 2013 Oct 28.

11.

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers.

Tomizawa K, Suda K, Onozato R, Kosaka T, Endoh H, Sekido Y, Shigematsu H, Kuwano H, Yatabe Y, Mitsudomi T.

Lung Cancer. 2011 Oct;74(1):139-44. doi: 10.1016/j.lungcan.2011.01.014. Epub 2011 Feb 25.

PMID:
21353324
12.

Analysis of ERBB4 mutations and expression in japanese patients with lung cancer.

Tomizawa K, Suda K, Onozato R, Kuwano H, Yatabe Y, Mitsudomi T.

J Thorac Oncol. 2010 Nov;5(11):1859-61. doi: 10.1097/JTO.0b013e3181f1c433.

13.

Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib.

Katayama T, Shimizu J, Suda K, Onozato R, Fukui T, Ito S, Hatooka S, Sueda T, Hida T, Yatabe Y, Mitsudomi T.

J Thorac Oncol. 2009 Nov;4(11):1415-9. doi: 10.1097/JTO.0b013e3181b62572.

14.

Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma.

Kosaka T, Yatabe Y, Onozato R, Kuwano H, Mitsudomi T.

J Thorac Oncol. 2009 Jan;4(1):22-9. doi: 10.1097/JTO.0b013e3181914111.

15.

Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers.

Onozato R, Kosaka T, Kuwano H, Sekido Y, Yatabe Y, Mitsudomi T.

J Thorac Oncol. 2009 Jan;4(1):5-11. doi: 10.1097/JTO.0b013e3181913e0e.

16.

EGFR T790M mutation: a double role in lung cancer cell survival?

Suda K, Onozato R, Yatabe Y, Mitsudomi T.

J Thorac Oncol. 2009 Jan;4(1):1-4. doi: 10.1097/JTO.0b013e3181913c9f. Review.

17.

Immunohistochemical analysis of phosphorylated epidermal growth factor receptor might provide a surrogate marker of EGFR mutation.

Endoh H, Ishibashi Y, Yamaki E, Yoshida T, Yajima T, Kimura H, Kosaka T, Onozato R, Tanaka S, Mitsudomi T, Kuwano H.

Lung Cancer. 2009 Feb;63(2):241-6. doi: 10.1016/j.lungcan.2008.05.013. Epub 2008 Jun 27.

PMID:
18585821
18.

LKB1 gene mutations in Japanese lung cancer patients.

Onozato R, Kosaka T, Achiwa H, Kuwano H, Takahashi T, Yatabe Y, Mitsudomi T.

Cancer Sci. 2007 Nov;98(11):1747-51. Epub 2007 Aug 16.

19.

Intraductal papillary mucinous tumor of the pancreas associated with autosomal dominant polycystic kidney disease.

Naitoh H, Shoji H, Ishikawa I, Watanabe R, Furuta Y, Tomozawa S, Igarashi H, Shinozaki S, Katsura H, Onozato R, Kudoh M.

J Gastrointest Surg. 2005 Jul-Aug;9(6):843-5.

PMID:
15985242

Supplemental Content

Loading ...
Support Center